BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28557480)

  • 1. Patient-reported outcome measures in Huntington disease: Quality of life in neurological disorders (Neuro-QoL) social functioning measures.
    Carlozzi NE; Hahn EA; Goodnight SM; Kratz AL; Paulsen JS; Stout JC; Frank S; Miner JA; Cella D; Gershon RC; Schilling SG; Ready RE
    Psychol Assess; 2018 Apr; 30(4):450-458. PubMed ID: 28557480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating cognition in individuals with Huntington disease: Neuro-QoL cognitive functioning measures.
    Lai JS; Goodnight S; Downing NR; Ready RE; Paulsen JS; Kratz AL; Stout JC; McCormack MK; Cella D; Ross C; Russell J; Carlozzi NE
    Qual Life Res; 2018 Mar; 27(3):811-822. PubMed ID: 29222609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.
    Carlozzi NE; Goodnight S; Kratz AL; Stout JC; McCormack MK; Paulsen JS; Boileau NR; Cella D; Ready RE
    J Huntingtons Dis; 2019; 8(4):467-482. PubMed ID: 31424415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responsiveness to Change Over Time: An Examination of the Neuro-QoL Social Function Measures in Persons with Huntington's Disease.
    Carlozzi NE; Boileau NR; Hahn EA; Barton SK; Cella D; McCormack MK; Ready RE
    J Huntingtons Dis; 2020; 9(1):83-97. PubMed ID: 31744014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD).
    Carlozzi NE; Boileau NR; Roché MW; Ready RE; Perlmutter JS; Chou KL; Barton SK; McCormack MK; Stout JC; Cella D; Miner JA; Paulsen JS
    Qual Life Res; 2020 Dec; 29(12):3419-3439. PubMed ID: 32813263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability and Validity of the HD-PRO-TriadTM, a Health-Related Quality of Life Measure Designed to Assess the Symptom Triad of Huntington's Disease.
    Boileau NR; Stout JC; Paulsen JS; Cella D; McCormack MK; Nance MA; Frank S; Lai JS; Carlozzi NE
    J Huntingtons Dis; 2017; 6(3):201-215. PubMed ID: 28968239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Calibration of the TBI-QOL Ability to Participate in Social Roles and Activities and TBI-QOL Satisfaction With Social Roles and Activities Item Banks and Short Forms.
    Heinemann AW; Kisala PA; Boulton AJ; Sherer M; Sander AM; Chiaravalloti N; Bushnik T; Hanks R; Roth E; Tulsky DS
    Arch Phys Med Rehabil; 2020 Jan; 101(1):20-32. PubMed ID: 31473208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD).
    Carlozzi NE; Schilling SG; Lai JS; Paulsen JS; Hahn EA; Perlmutter JS; Ross CA; Downing NR; Kratz AL; McCormack MK; Nance MA; Quaid KA; Stout JC; Gershon RC; Ready RE; Miner JA; Barton SK; Perlman SL; Rao SM; Frank S; Shoulson I; Marin H; Geschwind MD; Dayalu P; Goodnight SM; Cella D
    Qual Life Res; 2016 Oct; 25(10):2441-2455. PubMed ID: 27522213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDQLIFE and neuro-QoL physical function measures: Responsiveness in persons with huntington's disease.
    Carlozzi NE; Boileau NR; Chou KL; Ready RE; Cella D; McCormack MK; Miner JA; Dayalu P
    Mov Disord; 2020 Feb; 35(2):326-336. PubMed ID: 31724237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system).
    Carlozzi NE; Downing NR; McCormack MK; Schilling SG; Perlmutter JS; Hahn EA; Lai JS; Frank S; Quaid KA; Paulsen JS; Cella D; Goodnight SM; Miner JA; Nance MA
    Qual Life Res; 2016 Oct; 25(10):2403-2415. PubMed ID: 27393121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric properties and responsiveness of Neuro-QoL Cognitive Function in persons with Huntington disease (HD).
    Carlozzi NE; Boileau NR; Paulsen JS; Downing NR; Ready R; Perlmutter JS; Cella D; Chou KL; McCormack MK; Barton S; Lai JS
    Qual Life Res; 2020 May; 29(5):1393-1403. PubMed ID: 31853881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcomes in Huntington's disease: Quality of life in neurological disorders (Neuro-QoL) and Huntington's disease health-related quality of life (HDQLIFE) physical function measures.
    Carlozzi NE; Ready RE; Frank S; Cella D; Hahn EA; Goodnight SM; Schilling SG; Boileau NR; Dayalu P
    Mov Disord; 2017 Jul; 32(7):1096-1102. PubMed ID: 28556412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of a new computer adaptive test to evaluate chorea in Huntington disease: HDQLIFE Chorea.
    Carlozzi NE; Downing NR; Schilling SG; Lai JS; Goodnight SM; Miner JA; A Frank S
    Qual Life Res; 2016 Oct; 25(10):2429-2439. PubMed ID: 27141833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the first quality-of-life measurement for patients with Huntington's disease: the Huntington Quality of Life Instrument.
    Clay E; De Nicola A; Dorey J; Squitieri F; Aballéa S; Martino T; Tedroff J; Zielonka D; Auquier P; Verny C; Toumi M
    Int Clin Psychopharmacol; 2012 Jul; 27(4):208-14. PubMed ID: 22508443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDQLIFE: the development of two new computer adaptive tests for use in Huntington disease, Speech Difficulties, and Swallowing Difficulties.
    Carlozzi NE; Schilling SG; Lai JS; Perlmutter JS; Nance MA; Waljee JF; Miner JA; Barton SK; Goodnight SM; Dayalu P
    Qual Life Res; 2016 Oct; 25(10):2417-2427. PubMed ID: 27038054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships Among Apathy, Health-Related Quality of Life, and Function in Huntington's Disease.
    Fritz NE; Boileau NR; Stout JC; Ready R; Perlmutter JS; Paulsen JS; Quaid K; Barton S; McCormack MK; Perlman SL; Carlozzi NE;
    J Neuropsychiatry Clin Neurosci; 2018; 30(3):194-201. PubMed ID: 29558861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions of the impact of chorea on health-related quality of life in Huntington disease (HD): A qualitative analysis of individuals across the HD spectrum, family members, and clinicians.
    Sherman CW; Iyer R; Abler V; Antonelli A; Carlozzi NE
    Neuropsychol Rehabil; 2020 Jul; 30(6):1150-1168. PubMed ID: 30849283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and psychometric characteristics of the SCI-QOL Ability to Participate and Satisfaction with Social Roles and Activities item banks and short forms.
    Heinemann AW; Kisala PA; Hahn EA; Tulsky DS
    J Spinal Cord Med; 2015 May; 38(3):397-408. PubMed ID: 26010974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive Affect and Well-Being in Huntington's Disease Moderates the Association Between Functional Impairment and HRQOL Outcomes.
    Ready RE; Boileau NR; Barton SK; Lai JS; McCormack MK; Cella D; Fritz NE; Paulsen JS; Carlozzi NE
    J Huntingtons Dis; 2019; 8(2):221-232. PubMed ID: 31045519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in Huntington's disease: a comparative study investigating the impact for those with pre-manifest and early manifest disease, and their partners.
    Read J; Jones R; Owen G; Leavitt BR; Coleman A; Roos RA; Dumas EM; Durr A; Justo D; Say M; Stout JC; Tabrizi SJ; Craufurd D;
    J Huntingtons Dis; 2013; 2(2):159-75. PubMed ID: 25063513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.